Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Explore the best investments to make money fast and learn how to maximize your returns. Start investing smartly today.
20,266 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Axon Enterprise stock popped as investors weighed the company’s expanding product lineup, software growth, and a grow...
A growing number of retirees are weighing a single-premium immediate annuity that pays $2,600 a month from a $400,000...
U.S. stocks opened the second half of 2026 with a cautious tone as chip stock profit-taking cooled a brisk first half...
AI funding is surging in 2026, signaling a new investment wave. Here's how an investor ahead next investment can posi...
Tesla reports a robust quarter with deliveries around 515,000, topping expectations and reigniting investor optimism....
As Netflix prepares to report its second-quarter results on July 16, many investors wonder if the company can sustain...
Dram stocks surged on AI-driven demand, yet the rally carries volatility and a stubborn supply gap. This analysis exp...
Bitcoin Suisse has secured regulatory clearance to offer institutional digital asset services in the UAE. The move ma...
Synopsys rides AI-driven demand in EDA and IP, delivering solid quarterly results and a robust backlog as the AI buil...
Palantir tops $300 billion in market value as Q1 2026 results reveal record growth and expanding margins. The milesto...
Howard Hanna NYC launches a major hiring spree, adding 26 agents to its Manhattan operation. The move includes the An...